Abstract
Background: The development of gonadotropin-independent (peripheral) precocious puberty in male children with primary adrenal insufficiency (PAI) is consistent with a defect in the genes encoding for the enzymes involved in steroid hormone biosynthesis. Methods: Two young boys presented with peripheral precocious puberty followed by PAI. In both patients, the analysis of CYP21A2 gene encoding 21-hydroxylase was normal. As a second step, a targeted next-generation sequencing (NGS) was performed in both patients using a customized panel of congenital endocrine disor ders. Results: Case 1 had a new homozygous variant in the CYP11B1 gene (c.1121+5G>A). Mutations of this gene cause congenital adrenal hyperplasia due to 11β-hydroxylase deficiency, an essential enzyme in the cortisol biosynthesis pathway. Case 2 showed a new hemizygous mutation in the NR0B1 gene (c.1091T>G), which encodes for DAX1 (dosage-sensitive sex reversal, adrenal hypoplasia congenita [AHC] and critical region on the X chromosome gene 1). NR0B1 mutations cause X-linked AHC and hypogonadotropic hypogonadism. Pathogenicity prediction software defined both mutations as probably damaging. Conclusions: Peripheral precocious puberty was the atypical presentation of 2 rare genetic diseases. The use of NGS made the characterization of these 2 cases with similar clinical phenotypes caused by 2 different genetic defects possible.
Journal Section:
Novel Insights from Clinical Practice
References
1.
Charmandari
E
, Nicolaides
NC
, Chrousos
GP
. Adrenal insufficiency
. Lancet
. 2014
Jun
;383
(9935
):2152
–67
.
[PubMed]
0140-67362.
Baranowski
ES
, Arlt
W
, Idkowiak
J
. Monogenic disorders of adrenal steroidogenesis
. Horm Res Paediatr
. 2018
;89
(5
):292
–310
.
[PubMed]
1663-28183.
Bulsari
K
, Falhammar
H
. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
. Endocrine
. 2017
Jan
;55
(1
):19
–36
.
[PubMed]
1355-008X4.
Kyritsi
EM
, Sertedaki
A
, Chrousos
G
, Charmandari
E
. Familial or Sporadic Adrenal Hypoplasia Syndrome. 2015 Apr 6. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000
-. Available from http://www.ncbi.nlm.nih.gov/books/NBK2791325.
Zanaria
E
, Muscatelli
F
, Bardoni
B
, Strom
TM
, Guioli
S
, Guo
W
, et al.. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita
. Nature
. 1994
Dec
;372
(6507
):635
–41
.
[PubMed]
0028-08366.
Iyer
AK
, McCabe
ER
. Molecular mechanisms of DAX1 action
. Mol Genet Metab
. 2004
Sep-Oct
;83
(1-2
):60
–73
.
[PubMed]
1096-71927.
Muscatelli
F
, Strom
TM
, Walker
AP
, Zanaria
E
, Récan
D
, Meindl
A
, et al.. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
. Nature
. 1994
Dec
;372
(6507
):672
–6
.
[PubMed]
0028-08368.
Domenice
S
, Latronico
AC
, Brito
VN
, Arnhold
IJ
, Kok
F
, Mendonca
BB
. Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene
. J Clin Endocrinol Metab
. 2001
Sep
;86
(9
):4068
–71
.
[PubMed]
0021-972X9.
Wiltshire
E
, Couper
J
, Rodda
C
, Jameson
JL
, Achermann
JC
. Variable presentation of X-linked adrenal hypoplasia congenita
. J Pediatr Endocrinol Metab
. 2001
Sep-Oct
;14
(8
):1093
–6
.
[PubMed]
0334-018X10.
Loke
KY
, Poh
LK
, Lee
WW
, Lai
PS
. A case of X-linked adrenal hypoplasia congenita, central precocious puberty and absence of the DAX-1 gene: implications for pubertal regulation
. Horm Res
. 2009
;71
(5
):298
–304
.
[PubMed]
1423-004611.
Schonfeld
WA
, Beebe
GW
. Normal growth and variation in the male genitalia from birth to maturity
. J Urol
. 1942
;48
(6
):759
–77
. 0022-534712.
Greulich
W
, Pyle
S
. Radiographic atlas of skeletal development of the hand and wrist
. 2nd ed.Stanford (CA)
: Stanford University Press
; 1971
.13.
Tanner
JM
, Whitehouse
RH
. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty
. Arch Dis Child
. 1976
Mar
;51
(3
):170
–9
.
[PubMed]
0003-988814.
Nagata
K
, Randall
A
, Baldi
P
. SIDEpro: a novel machine learning approach for the fast and accurate prediction of side-chain conformations
. Proteins
. 2012
Jan
;80
(1
):142
–53
.
[PubMed]
0887-358515.
Khattab
A
, Haider
S
, Kumar
A
, Dhawan
S
, Alam
D
, Romero
R
, et al.. Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
. Proc Natl Acad Sci USA
. 2017
Mar
;114
(10
):E1933
–40
.
[PubMed]
0027-842416.
Darcan
S
, Goksen
D
, Ozen
S
, Ozkinay
F
, Durmaz
B
, Lalli
E
. Gonadotropin-dependent precocious puberty in a patient with X-linked adrenal hypoplasia congenita caused by a novel DAX-1 mutation
. Horm Res Paediatr
. 2011
Feb
;75
(2
):153
–6
.
[PubMed]
1663-281817.
Katsumata
N
, Tanae
A
, Shinagawa
T
, Nimura
A
, Horikawa
R
, Tanaka
T
. Precocious puberty in patient with adrenal hypoplasia congenital (abstract)
. Proceedings of the 79th Annual Meeting of the Endocrine Society
, Minneapolis
, 1997
, P2
–P512
.18.
Shima
H
, Yatsuga
S
, Nakamura
A
, Sano
S
, Sasaki
T
, Katsumata
N
, et al.. NR0B1 Frameshift Mutation in a Boy with Idiopathic Central Precocious Puberty
. Sex Dev
. 2016
;10
(4
):205
–9
.
[PubMed]
1661-542519.
Qian
J
, Wang
X
, Liu
J
, Zhong
J
, Le
Y
, Melchior Tellier
LC
, et al.. Applying targeted next generation sequencing to dried blood spot specimens from suspicious cases identified by tandem mass spectrometry-based newborn screening
. J Pediatr Endocrinol Metab
. 2017
Aug
;30
(9
):979
–88
.
[PubMed]
0334-018X© 2018 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2018
You do not currently have access to this content.
